The recent disruptions in global supply have highlighted the importance of securing essential medications like Ivermectin. Trusting on overseas producers exposes regions to significant vulnerabilities, including delivery delays, cost fluctuations, and even geopolitical concerns. Transitioning towards domestic production of Ivermectin offers a multi